Cardiometabolic Health Congress

JUNE 24, 2024

As a leader in the field of research-based cardiometabolic health education, CMHC is proud to present its CME education outcomes study at ADA (American Diabetes Association) 2024 Scientific Sessions, which offers its education-focused agenda to a wide number of healthcare practitioners from all areas of the U.S.

Patient Care 52

Patient Care Obesity Education CME 52

American College of Cardiology

FEBRUARY 12, 2024

What is the value of the new American Heart Association’s (AHA’s) PREVENT equation(s) for primary prevention that use routinely available clinical variables including obesity, diabetes, kidney disease, and social risk for predicting 10- and 30-year absolute risk of cardiovascular disease (CVD) including each atherosclerotic CVD (ASCVD) and heart (..)

Kidney Disease 48

Kidney Disease Obesity Heart Failure Cardiovascular Disease 48

Journal of the American Heart Association

MARCH 25, 2025

BackgroundIn 2023, the American Heart Association defined the concept of cardiovascularkidneymetabolic (CKM) syndrome as a health disorder ascribed to connections among obesity, diabetes, chronic kidney disease, and cardiovascular disease. CKM syndrome stages 3 and 4 are considered advanced.

Kidney Disease 40

Kidney Disease Cardiovascular Disease Risk Factors Obesity 40

Cardiometabolic Health Congress

AUGUST 14, 2024

Themed “Decoding the Constellation of Cardiometabolic Health and Risk Factors,” this year’s congress will tackle the growing health threat posed by cardiometabolic diseases, affecting 47 million people in the US. Singh, MBBS, FRCP, MBA Advances in Obesity Pharmacotherapy Louis J. When I heard of his passing, I felt quite sad.

CME 72

CME Education Diabetes Innovation 72

Cardiometabolic Health Congress

JULY 12, 2023

For instance, a pediatric provider may be only interested in topics pertaining to childhood obesity. They could find resources and education focused on that condition within both the Obesity Management and Pediatrics hubs.

Education 40

Education Webinar CME Pediatrics 40

Cardiometabolic Health Congress

NOVEMBER 8, 2023

2023, the American Heart Association (AHA) issued a presidential advisory on the urgency of this systemic disorder involving heart disease, kidney disease, diabetes and obesity. The virtual, self-paced Foundations of Cardiometabolic Health Certificate Course is the first step to attaining the CCHP credential.

Certification 52

Certification Nursing Kidney Disease Education 52

Cardiometabolic Health Congress

OCTOBER 26, 2023

A session at the 18 th Annual Cardiometabolic Health Congress (CMHC), explored the intersection of cardiometabolic conditions such as obesity and insulin resistance with liver disease, beginning with some important new updates on the preferred terms for these diseases. Nonalcoholic fatty liver disease (NAFLD) & NASH.

Diabetes 52

Diabetes Kidney Disease Obesity Anatomy 52

Circulation: Heart Failure

MARCH 8, 2024

The prevalence of HF risk factors was high: hypertension, 61.9%; former or current smoking, 53.7%; obesity 34.8%; diabetes; 24.7%; and chronic kidney disease; 22%. Overt cardiovascular disease, which ranged from 2.1% (HF) to 13.6% (atrial fibrillation), was less common. were female, 25.6% were Black, 12.8%

Heart Failure 40

Heart Failure Atherosclerosis Kidney Disease Risk Factors 40

Stroke Journal

FEBRUARY 1, 2024

to 2.26) and liver disease (OR 2.20, p < 0.01, CI 1.27 Regarding comorbidities, congestive heart failure (OR 1.73, p <0.01, CI 1.32

Inpatient 40

Inpatient Stroke Strokes Coronary Artery Disease 40

DAIC

DECEMBER 8, 2023

“The new guideline reinforces the urgent need to approach AFib as a complex cardiovascular condition that requires disease prevention, risk factor modification, as well as optimizing therapies and patients’ access to care and ongoing, long-term management.” For example, kidney disease is not included in CHA 2 DS 2 -VASc.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Stroke Strokes 52

GEMMS

MAY 22, 2024

Gene-Based Analysis Predictive analytics is vital in reducing morbidity and mortality, with healthcare startups focusing on early risk prediction and disease detection. Much of heart disease is linked to conditions like diabetes, obesity, or chronic kidney disease, and specific mutations in nucleic acids help identify them.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

DAIC

MARCH 26, 2025

2 Most are balancing multiple comorbidities, such as obesity, diabetes, hypertension and chronic kidney disease (CKD). A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease (FIND-CKD). Diabetes Care. 4 Approximately 6.7

Heart Failure 52

Heart Failure Preserved Ejection Fraction Kidney Disease ACE Inhibitor 52

Cardiometabolic Health Congress

JULY 25, 2023

Can you please explain the concept of an obesity paradox? Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. 2, 3] This association is more pronounced for those with class I obesity, which is a body mass index (BMI) between 30-35 kg/m2.

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

DAIC

SEPTEMBER 11, 2024

A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. Earlier projections had estimated that 3.3 million U.S. The study appears Sept. The study appears Sept.

Atrial Fibrillation 92

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 92

CardiacWire

OCTOBER 27, 2024

It’s well known that heart disease is the U.S.’s s top cause of death, and our rising CVD rates have been widely covered, but a look back on some of the biggest stories of 2024 suggests that cardiovascular disease is about to become a much bigger problem. trillion, representing 4.6% of US GDP.

AFIB 59

AFIB Hypertension Kidney Disease Heart Disease 59

DAIC

SEPTEMBER 11, 2024

A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. Earlier projections had estimated that 3.3 million U.S. The study appears Sept. The study appears Sept.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 52

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

Measuring eGFR and albuminuria is recommended for assessing kidney disease in all hypertensive patients. Below are some of the most notable highlights: 2024 ESC Updated Clinical Guidelines: Key updates include clopidogrel as a first-line option for long-term use after MI or PCI.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

Stroke Journal

FEBRUARY 1, 2024

FD residents were significantly more likely to have comorbid hypertension (OR 1.14, 95%CI 1.09, 1.19), type 2 diabetes (OR 1.21, 95%CI 1.17, 1.25), heart failure (OR 1.14, 95%CI 1.09, 1.19), and chronic kidney disease (OR 1.24, 95%CI 1.18, 1.30) associated with acute stroke hospital admission.

Risk Factors 40

Risk Factors Stroke Strokes Health Disparities 40

Physiologically Speaking

DECEMBER 15, 2023

Blood glucose control Resistance exercise training can reduce fasting glucose by 2–5 mg/dL in adults with prediabetes and type 2 diabetes but doesn’t seem to reduce blood glucose in healthy adults (not surprising). a higher metabolism). Of course, these benefits can also extend to individuals with a BMI in the normal range.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Physiologically Speaking

DECEMBER 15, 2023

Blood glucose control Resistance exercise training can reduce fasting glucose by 2–5 mg/dL in adults with prediabetes and type 2 diabetes but doesn’t seem to reduce blood glucose in healthy adults (not surprising). a higher metabolism). Of course, these benefits can also extend to individuals with a BMI in the normal range.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

DAIC

JANUARY 23, 2024

11 Despite the link between inflammation and cardiovascular disease has been proven by extensive research, most physicians have focused on treating high-risk patients with lipid lowering therapies including statin therapy.1,12,13 For most individuals, these gastrointestinal effects markedly attenuate with longer-term therapy.34 μ/L on 0.6

Cardiovascular Disease 111

Cardiovascular Disease Heart attacks Heart Attack Coronary Artery Disease 111

Physiologically Speaking

FEBRUARY 26, 2024

And that’s exactly when obesity began a meteoric rise. Another study found that they don’t get diabetes and kidney diseases (the ninth leading cause of death). But the food industry started leveraging it with the rise of ultraprocessed snack foods in the 1970s. I write about nutrition quite a bit.

Diet 52

Diet Cardiovascular Disease Exercise Research 52

Physiologically Speaking

MAY 3, 2024

It’s been well-established that males and females respond differently to exercise. This was also observed in the current analysis — in which 58% of the training-induced responses were different between the sexes.

Exercise 95

Exercise Physiology Research Kidney Disease 95

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Cardiovascular disease remains the leading cause of death worldwide , claiming 18 million lives annually. 42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. In the U.S.,

CME 103

CME Obesity Heart Failure Biomarkers 103

DAIC

APRIL 17, 2025

Previous research indicates the rate ofischemic(clot-caused) stroke among adults 18-49 years old is increasing and propelled by a corresponding rise incryptogenicstrokes (strokes of unknown cause) in adults without traditional risk factors, including high blood pressure, smoking, obesity, high cholesterol andType 2 diabetes.

Risk Factors 52

Risk Factors Stroke Strokes Blood Pressure 52